Tolerability of olaparib tablets as maintenance therapy in patients with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2/AGO-OVAR2.23 trial - Hanker, LC; Heitz, F; Park-Simon, TW; Gropp-Meier, M; Ataseven, B; Pujade-Lauraine, E; Harter, P (Geburtshilfe und Frauenheilkunde, 2018)